title: Biapenem American Cyanamid Co.
abstract: Biapenem is an injectable carbapenem antibiotic with activity against a broad spectrum of bacteria [155679]. It has been submitted for marketing approval in Japan by Lederle Japan, a joint venture between Cyanamid and Takeda. Biapenem is in phase III trials in Germany, South Africa, Spain, Australia and New Zealand for skin infections, and phase I trials in the UK and the US.
authors.affiliation: R W Johnson Pharmaceutical Research Institute, Welsh and McKean Roads, R-439, Spring House, PA 19477-0776, USA. SDax@prius.jnj.com
authors.forename: S L
authors.initials: SL
authors.lastname: Dax